Universitätsklinikum Hamburg-Eppendorf (UKE)

Hospital


Location: Hamburg, Germany (DE) DE

ISNI: 0000000121803484

ROR: https://ror.org/01zgy1s35

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2021) Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, et al. Journal article Idecabtagene vicleucel in relapsed and refractory multiple myeloma (2021) Munshi NC, Anderson LD, Shah N, Madduri D, Berdeja J, Lonial S, Raje N, et al. Journal article Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women (2021) Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, Pooley KA, et al. Journal article The “VIP-ADHD trial”: Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients? (2021) Strauß M, Petroff D, Huang J, Ulke C, Paucke M, Bogatsch H, Böhme P, et al. Journal article 4. Ringversuch Arzneimittelinformation der ADKA. Frage und Musterantwort (2021) Strobach D, Blassmann U, Klausner S, Krebs S, Langebrake C, Querbach C, Schuhmacher C Journal article Dermatological Quality of Life and Neurodermatitis: Results from the German Neurodermatitis Registry TREATgermany (2021) Helmert C, Haufe E, Abraham S, Heratizadeh A, Harder I, Kleinheinz A, Wollenberg A, et al. Conference contribution Heart failure in the young: Insights into myocardial recovery with ventricular assist device support (2021) Delmo EMJ, Javier MFDM, Boethig D, Ruffer A, Cesnjevar R, Dandel M, Hetzer R Journal article Efficacy of the tyrosine kinase inhibitor lapatinib in the treatment of patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells - results from the randomized phase III DETECT III trial (2021) Fehm T, Mueller V, Banys-Paluchowski M, Fasching P, Friedl TWP, Hartkopf A, Huober J, et al. Conference contribution Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program (2021) Muller V, Banys-Paluchowski M, Friedl TWP, Fasching P, Schneeweiss A, Hartkopf A, Wallwiener D, et al. Journal article Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry—comparison of three different GPA prognostic scores (2021) Riecke K, Müller V, Weide R, Schmidt M, Park‐simon TW, Möbus V, Mundhenke C, et al. Journal article